What is a stock summary page? Click here for an overview.
Business Description
Nanobiotix SA
NAICS : 325412
SIC : 2834
ISIN : FR0011341205
Compare
Compare
Traded in other countries / regions
NANO.FranceNBTX.USA0QAV.UK5NR.Germany IPO Date
2016-04-08Description
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.98 | |||||
| Equity-to-Asset | -0.98 | |||||
| Debt-to-Equity | -0.78 | |||||
| Debt-to-EBITDA | -0.87 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -3.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 1.4 | |||||
| 3-Year EPS without NRI Growth Rate | -0.1 | |||||
| 3-Year FCF Growth Rate | 20.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 73.85 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.25 | |||||
| 9-Day RSI | 33.77 | |||||
| 14-Day RSI | 37.17 | |||||
| 3-1 Month Momentum % | 2.5 | |||||
| 6-1 Month Momentum % | -32.53 | |||||
| 12-1 Month Momentum % | -47.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.04 | |||||
| Quick Ratio | 1.04 | |||||
| Cash Ratio | 0.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.8 | |||||
| Shareholder Yield % | 1.64 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | 589.12 | |||||
| Net Margin % | 586.89 | |||||
| FCF Margin % | 175.72 | |||||
| ROA % | -82.42 | |||||
| ROIC % | -197.18 | |||||
| 3-Year ROIIC % | -452.64 | |||||
| ROC (Joel Greenblatt) % | -1016.25 | |||||
| ROCE % | -217.53 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -2.3 | |||||
| EV-to-EBITDA | -2.37 | |||||
| EV-to-Revenue | -11.88 | |||||
| EV-to-Forward-Revenue | 4.09 | |||||
| EV-to-FCF | -6.77 | |||||
| Price-to-GF-Value | 1.6 | |||||
| Earnings Yield (Greenblatt) % | -43.55 | |||||
| FCF Yield % | -14.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nanobiotix SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | -11.609 | ||
| EPS (TTM) (€) | -1.44 | ||
| Beta | -1.12 | ||
| 3-Year Sharpe Ratio | 0.13 | ||
| 3-Year Sortino Ratio | 0.3 | ||
| Volatility % | 52 | ||
| 14-Day RSI | 37.17 | ||
| 14-Day ATR (€) | 0.145795 | ||
| 20-Day SMA (€) | 3.2149 | ||
| 12-1 Month Momentum % | -47.13 | ||
| 52-Week Range (€) | 2.68 - 6.895 | ||
| Shares Outstanding (Mil) | 47.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nanobiotix SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nanobiotix SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nanobiotix SA Frequently Asked Questions
What is Nanobiotix SA(LTS:0QAV)'s stock price today?
The current price of LTS:0QAV is €2.91. The 52 week high of LTS:0QAV is €6.90 and 52 week low is €2.68.
When is next earnings date of Nanobiotix SA(LTS:0QAV)?
The next earnings date of Nanobiotix SA(LTS:0QAV) is 2025-05-22 Est..
Does Nanobiotix SA(LTS:0QAV) pay dividends? If so, how much?
Nanobiotix SA(LTS:0QAV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers